News
SRD Search launches on VIDAL with first pharmaceutical company, Pfizer
Nov 16, 2026
Pharmaceutical industry gains route to French healthcare professionals as SRD Search launches on VIDAL, with Pfizer first to join.
Leatherhead, 16 November 2026:
Datapharm, the company behind emc, the UK’s trusted source of regulatory-approved medicines information, has announced the launch of its SRD Search functionality on VIDAL in France.
Pfizer is the first manufacturer to make its Scientific Response Documents (SRDs) available to French healthcare professionals (HCPs) through the service. Since going live in August 2026, Pfizer has published 373 French SRDs covering nine of its brands.
France is the third market for SRD Search, following the UK on emc and Germany on Rote Liste. Fourteen pharmaceutical companies currently use the service across the three markets, with take-up continuing to grow.
Search data from the UK and Germany has already shown that HCP behaviour differs by market. In Germany, nine in ten searches are a single word and more than half are typed in English rather than German. In both markets, a significant share of searches happens outside the hours a Medical Information service is typically staffed.
The launch on VIDAL marks the start of building the same level of insight for France. Participating manufacturers receive analytics reports showing what French HCPs search for, when they search and which questions go unanswered, helping them refine their SRD content for the French market.
Rob Morgan, Chief Executive Officer, Datapharm, said: "Healthcare professionals need answers they can trust, yet increasingly the first answer they see comes from a tool that cannot distinguish a verified response from an invented one. Manufacturers have already done the hard work of writing and reviewing these documents. SRD Search puts that trusted content where French HCPs already look, at any hour. Launching on VIDAL with Pfizer is an important step in expanding access to trusted medicine information across Europe, and the beginning of understanding how French HCPs search."
Aqid Iqbal, Europe and Canada Medical Information Operations Manager, Pfizer, said: Expanding access to Pfizer Medical Information through VIDAL is an important step in our Medical Information strategy of easing access and expanding reach. We are proud that Pfizer is the first manufacturer to make Scientific Response Documents available through this new service on VIDAL. By making trusted Pfizer Scientific Response Documents available through a resource healthcare professionals in France already use, we are enabling greater self-service access to medical information, where and when it is needed. This collaboration builds on our work to bring trusted scientific information closer to healthcare professionals through established digital channels, helping ensure that the science behind our breakthroughs is supported by accessible medical information for those caring for patients.”
Ferran Portella, Managing Director of VIDAL Group’s Medical Knowledge Solutions division, said: "VIDAL's role is to provide French healthcare professionals with accurate and reliable information on medicines. SRD Search extends what they can find on vidal.fr with approved, in-depth responses from manufacturers, accessible 24/7 whenever they need to make a prescription decision. We are pleased to welcome Pfizer as the first manufacturer on the service."
About Pfizer
Pfizer is a global biopharmaceutical company that discovers, develops, manufactures and distributes medicines and vaccines. Its portfolio spans areas including oncology, vaccines, inflammation and immunology, and internal medicine, and it works with healthcare providers, governments and communities around the world to improve access to reliable, affordable healthcare. Pfizer is headquartered in New York and has an extensive network of subsidiaries and operations across Europe, including Pfizer Limited in the UK.
About VIDAL Group
VIDAL Group's mission is to contribute to the quality of care by providing healthcare professionals with integrated, precise, and actionable knowledge on health products and therapeutics. Its solutions — decision support, training, patient record management — are distributed across any type of digital platform used by caregivers. With teams in France, Germany, and Spain, and a fully multilingual knowledge base, VIDAL Group commercializes its solutions in 30 countries. In Europe, more than 700,000 healthcare professionals use them daily. VIDAL Group is an entity of the M3 group, the global leader in digital health, listed on the Tokyo Stock Exchange (2413.T).
Press contact for VIDAL :
Olivia Bertero, [email protected]
About Datapharm
Datapharm is a leading medicines information provider in the UK. Its medicines information database, emc (electronic medicines compendium) is the UK’s most comprehensive, trusted and accessible source of information on medicines, listing more than 10,000 medicines and attracting an audience of millions of users every year.
As a data company, Datapharm provides innovative solutions to support the Life Sciences and wider Healthcare sectors in their work with medicines information, serving more than 320 Pharma customers in the UK.
electronic medicines compendium (emc) - medicines.org.uk
Press contact for Datapharm:
Paula Murphy, [email protected]
About SRD Search
Scientific Response Documents (SRDs) are developed by Pharma to address frequently asked questions about medicines. They provide essential information that enables HCPs to evaluate the treatment’s appropriateness for specific circumstances, conditions, and patients. SRD search technology, developed with MILE (Medical Information Leaders in Europe), enables HCPs to search online and retrieve accurate responses they can trust to their specific questions about medicines.